MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore Hypopigmentation-Punctate Palmoplantar Keratoderma Syndrome, its genetic causes, and how genetic testing aids in diagnosis, management, and family planning.
Explore Hypotrichosis 12, a rare genetic disorder affecting hair growth, and learn how genetic testing aids in diagnosis, family planning, and future treatments.
Explore how genetic testing uncovers mysteries of idiopathic CD4 lymphocytopenia, aiding diagnosis, personalized treatments, and improving patient outcomes.
Explore how genetic testing identifies mutations like STAT1 and IFIH1 in Immunodeficiency 14, improving diagnosis, personalized treatments, and family planning.
Uncover the FNIP1 mutation's role in Immunodeficiency 18 and cardiomyopathy. Explore how genetic testing aids in early diagnosis, personalized treatments, and family planning.
Explore the impact of genetic testing on Immunodeficiency 19, enhancing diagnosis, personalized treatment, risk assessment, and monitoring disease progression.
Explore how genetic testing identifies mutations in the NFKB2 gene, enabling precise CVID10 diagnosis, personalized treatments, and predictive insights for families.
Explore how genetic testing, especially Whole Exome Sequencing, aids in early diagnosis and personalized treatment for Intellectual Disability, Autosomal Dominant 27.